Study Of Adults And Adolescents With Vasomotor Rhinitis

Completed · Phase 3

Conditions studied: Rhinitis, Vasomotor

In brief

The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with vasomotor rhinitis (VMR).

Key facts

Study ID
NCT00117325
Run by
GlaxoSmithKline
People needed
352
Starts
2005-07-11
Expected to finish
2006-02-09
Last updated by the study team
2018-03-13

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.